Screening of Organoids Derived from Patients with Breast Cancer Implicates the Repressor NCOR2 in Cytotoxic Stress Response and Antitumor Immunity

High nuclear receptor corepressor 2 (NCOR2) in the tumors of patients with breast cancer predicted chemotherapy refractoriness, tumor recurrence and poor prognosis.